Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Surgery Type & End-User The global surgical robots market will witness a robust CAGR of 16.84%, valued at $5.16 billion in 2021, expected to appreciate and reach $20.98 billion by 2030, confirms Strategic Market Research. North America currently has the largest market share by region, with a valuation of around USD 3.27 billion. Surgical Robots enable doctors to perform complex procedures with greater precision, flexibility, and control than conventional techniques. It is commonly associated with minimally invasive surgeries and open procedures. The most popular system includes a camera arm and mechanical arms with surgical instruments attached. The surgeon controls the arms from a computer console, leading team members during the operation. Advancements in surgical technology have combined robots with AI to create minimally invasive surgeries, reducing wound size, bleeding, infection risk, and patient recovery time. An estimated 1638 surgical robots will be used for various applications in 2022. Surgical robots are mostly used in minimally invasive surgeries and sometimes in traditional open surgeries. As per the Agency for Healthcare Research and Quality, more than 450,000 total hip replacements are performed annually in the USA, thereby augmenting the market's overall growth. Key Market Drivers - Rising demand for Minimally Invasive procedures, High success rate of Robotic-Assisted Surgery, and Minimum Life-Threatening Complications of RAS The minimally invasive surgery market is growing with a CAGR of 8.45%, projected to reach $95 million by 2030. This exponential growth in minimally invasive surgeries fuels the prevalence of robot-assisted surgeries. Factors like smaller incisions, better precision, better visualization, quick healing, decreased blood loss & minimal patient risk are raising demand for minimally invasive robot-assisted procedures. Technological advancements in RAS with AI, VR & AR integration have increased patient satisfaction & awareness, raising the need for minimally invasive RAS. The robotic-assisted surgery registered a high success rate, leading to increased adoption of surgical robots. According to NCBI, the published data about the various robot-assisted surgeries showed excellent results & success rates, ranging between (94% and 100)%. This high success rate enables more end-users to adopt surgical robots, thus driving industry growth. The robotic-assisted surgery was also found to cause minimal life-threatening complications. 2021 robotic surgery statistics show that life-threatening complications rose only from 0 to 2% in robotic-assisted surgeries. These minimal life-threatening complications from robotic surgeries allowed more end-users to adopt surgical robots, thus increasing the overall surgical robots market share. Market Restraints - High Cost of Robot-Assisted Surgeries Average cost for robotic surgeries is $15,320, and this high cost limits the adoption and accessibility of surgical robots in the healthcare facilities. Robotic surgical systems have high fixed costs, with a capital investment of upto $2.5 million for each unit. Additionally, the systems need costly maintenance and upkeep, as well as additional consumables. The initial purchase price, ongoing maintenance, and potential upgrades acts as a restraint for hospitals and clinics with limited budgets. Market Opportunities - Integration of Artificial Intelligence in RAS, Newer Applications for Robotic-Assisted Surgeries AI-driven surgical robots assist surgeons in focusing on complex surgical tasks, reducing fluctuations and improving skills. They help identify critical insights and state-of-the-art practices by browsing through millions of data sets. AI-based systems can absorb vast amounts of information in seconds, enabling surgeons to learn and apply the best techniques in medical procedures. Learning from demonstration (LfD) is used for training robots to perform new tasks independently, breaking down complex tasks into subtasks and basic gestures. By integrating AI with robotic surgery platforms, AI can redefine surgical care, empowering physicians to address a wider patient population and launching the healthcare industry to new heights. Robotic-Assisted surgery has found newer applications recently. For example, robotic-arm assisted knee resurfacing, robotic heart surgery, robotic bladder surgery, robotic surgery for prostate cancer, minimally invasive neurosurgery, gynecologic surgery, endometriosis, thoracic surgery, and urologic surgery can all be done by surgical robots. This is expected to increase the overall size of the orthopedic, spinal, abdominal, and AI-based surgical robots market, respectively. Market Analysis Of Different Segments Covered in the Report Based on Application Orthopedics Neurology Urology Gynecology General Surgery Others Based on End-User Hospitals Ambulatory Surgical Centres Others Regional Coverage Analysis North America Canada United States of America Rest of North America Europe United Kingdom Germany Italy France Spain Russia Rest of Europe Asia-Pacific Australia China Japan India South Korea Singapore Rest of Asia-Pacific LAMEA Brazil Argentina South Africa Saudi Arabia United Arab Emirates Rest of LAMEA Segments Analysis & Insights The ‘General Surgery’ segment had the largest industry share by application, with around 29% in 2021. Due to the increasing use of surgical robots for cancer treatment and increasing demand for minimally invasive laparoscopic surgeries, the general surgery segment has captured a large market share. According to an NCBI study, nearly 60% of laparoscopic surgeries are performed using robots, which is expected to increase over time. The ‘hospital’ segment had the largest market share by end-user, with around 71.22%. The rising number of inpatient visits and the increasing number of surgical procedures drove the market growth in this segment. According to an NCBI study, 23 of 73 hospitals have performed robotic-assisted surgery, which is expected to rise. Due to the large US surgical robotics market size, North America had the largest share by region, valuing around USD 3.27 billion in 2022. The increasing availability of surgical robots, coupled with the growing number of injuries and diseases requiring surgery, is increasing in North America, which assists in driving the industry's growth. The European market is valued at around USD 2.17 billion in 2022. On the other hand, the Asia-Pacific region will be the fastest-growing industry, with a CAGR of 23.32% throughout the projected period. The rapidly developing technology in surgical robotics and the increasing patient population in developing markets like India and China have fostered segment growth. According to Intuitive Surgical, there are 170 da Vinci surgical robots in China that have performed over 170,000 surgeries. Surgical Robots Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 5.16 billion The revenue forecast in 2028 USD 20.98 billion Growth rate CAGR of approximately 16.84% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Application, End-Use, and Region By Application Orthopedics, Neurology, Urology, Gynaecology, General Surgery, Others By End-Use Hospitals, Ambulatory Surgical Centres By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Germany, United Kingdom, Italy, France, Spain, Russia, Canada, Australia, China, Japan, India, South Korea, Singapore, Brazil, Argentina, Saudi Arabia, United Arab Emirates, South Africa Company Usability Profiles Intuitive Surgical, Stryker Corporation, Medtronic, Smith & Nephew, Zimmer Biomet, Asensus Surgical (Transenterix), Corindus Vascular Robotics, Renishaw, Auris Health, Medrobotics Corporation, Think Surgical, Verb Surgical (part of Johnson and Johnson), OMNIlife Science, CMR Surgical, Preceyes BV, China National Scientific Instruments, and Materials Corporation, Microsure, Titan Medical, avateramedical GmbH, Medicaroid Corporation Global Surgical Robots Market Competitive Landscape Analysis The main companies in the industry mainly focus on new technology development and the introduction of next-generation robotic surgical instruments to help maintain their position in the market. In addition, the increasing demand for surgical robots will also facilitate the entry of new entrants into the market environment. Moreover, strategic industrial developments by leading competitors like mergers & acquisitions and collaborations are expected to boost the competition in the future. Intuitive Surgical (market share around 80% in 2022) Stryker Corporation Medtronic Smith & Nephew Zimmer Biomet Asensus Surgical (Transenterix) Corindus Vascular Robotics Renishaw Auris Health Medrobotics Corporation Think Surgical Verb Surgical (part of Johnson and Johnson) OMNIlife Science CMR Surgical Preceyes BV China National Scientific Instruments and Materials Corporation Microsure Titan Medical avateramedical GmbH Medicaroid Corporation Industry Recent Developments On June 2023, Apollo Hospitals, Ahmedabad, launched the Da Vinci Xi Robotic Surgical System, a ground-breaking advancement in surgical procedures. This state-of-the-art technology promises enhanced precision and superior patient care, revolutionizing surgical healthcare and improving clinical outcomes. The system is designed for Oncology, Urology, Colorectal, General Surgery, Gynaecology & Gastro-Intestinal surgeries, offering exceptional accuracy, efficiency & safety. Robotic surgery offers minimally invasive incisions, reduced scarring, and shorter recovery times compared to traditional methods. It also lowers complications like infections and scarring. On May 2023, Moon Surgical, a robotics startup, closed a $55.5 million funding round, raising its total funding to $90 million. The round was steered by Sofinnova Partners and NVentures, Nvidia's venture capital arm. Fred Moll, founder of Intuitive Surgical and Auris Health, was also an investor in the round. Moon focuses on developing and commercializing its Maestro system, a two-arm robotic system that enhances surgeons' capabilities by providing an extra set of arms and hands. The Maestro system has received FDA & European regulatory clearance and is set to be used in the U.S. & European Union laparoscopic procedures. On May 2023, Virtuoso Surgical introduced a new robotic surgery system to expand the scope of endoscopic surgery. The system consists of two 1mm diameter manipulators controlled by robots operating from a rigid endoscope. The endoscope is smaller than a 5-pence coin and can be equipped with various manipulators for various procedures. The system has shown feasibility in animal and tissue models and offers dexterity in processes involving tools delivered through rigid endoscopes. The CEO explains that Virtuoso allows surgeons to lift tissue, apply tension, and maintain traction in tight spaces, making it a ground-breaking advancement in endoscopic surgery. On May 2023, Smith+Nephew introduced two new products for its robotics and digital surgery portfolio, the data visualisation platform RI.Insights and personalised planning (powered by AI). By transforming data into contextual intelligence, these solutions help surgeons understand how preoperative strategies and intraoperative choices affect postoperative results. The Cori robotic surgery system for knee replacement is enhanced by Personalised Planning and RI.Insights, which let surgeons place the initial implant based on AI-guided reference values, patient preferences, and deformities. Surgeons will be able to compare the results of individual cases and benchmark data against a global anonymized database using RI.Insights as well. Various Surgical Robots that Key Market Leaders Develop. Name of the Product Function Key Player Versius+ Used for Minimal Access Surgery CMR Surgical Mako Used for Joint Replacement Surgery Stryker Corporation Da Vinci Used for Minimally Invasive Surgery Intuitive Surgical Hugo RAS system Portable and Modular system that allows surgery to be performed on any patient using any procedure and in any operating room Medtronic Frequently Asked Question About This Report How big is the surgical robots market? The global surgical robots market size was $5.16 billion in 2021 and is expected to reach $20.98 billion in 2030, with a CAGR of 16.84%. What companies make surgical robots? The surgical robot manufacturers include: Intuitive Surgical, Stryker Corporation, Medtronic, Smith & Nephew, Zimmer Biomet, Asensus Surgical (Transenterix), Corindus Vascular Robotics, Renishaw, Auris Health, Medrobotics Corporation, Think Surgical, Verb Surgical (part of Johnson and Johnson), OMNIlife Science, CMR Surgical, Preceyes BV, China National Scientific Instruments And Materials Corporation (CSIMC), Microsure, Titan Medical, avateramedical Gmbh and Medicaroid Corporation. How many surgical robots are there? There are an estimated 1638 surgical robots currently in use. What is the surgical robots market growth? The global surgical robots market is expected to grow at a compound annual growth rate (CAGR) of 16.84% from 2021 to 2030 to reach USD 20.98 billion by 2030. What are the current trends in surgical robotics? The advantages of robotic-assisted surgery, high success rate and minimum life-threatening conditions due to RAS are the latest trends in surgical robotics. What are the future trends in the surgical robotics market? The increasing penetration of robotic-assisted surgery and newer applications for surgical robots can help the market grow further. How many surgical robots are there in the world? There are an estimated 1638 surgical robots currently in the world. Is robotic surgery growing? Yes, the robotic surgery market is growing, with a CAGR of 16.84% Sources https://orthoinfo.aaos.org/en/treatment/total-hip-replacement/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104663/ https://www.chinadaily.com.cn/a/202011/06/WS5fa4e9bba31024ad0ba838f5.html https://investors.stryker.com/press-releases/news-details/2021/Stryker-acquires-OrthoSensor/default.aspx https://www.massdevice.com/smithnephew-unveils-ai-powered-surgical-robotics-tools/ https://www.medicaldevice-network.com/news/virtuoso-surgical-robotic-surgery-system/ https://medcitynews.com/2023/05/laparoscopy-robotics-surgery-healthcare-venture-capital/ https://www.apnnews.com/apollo-hospitals-unveils-next-generation-robotic-surgery-for-enhanced-precision/ https://www.mobihealthnews.com/news/contributed-power-ai-surgery https://www.forbes.com/sites/forbestechcouncil/2023/02/15/four-ways-artificial-intelligence-can-benefit-robotic-surgery/?sh=6ebde231859f https://www.ncbi.nlm.nih.gov/pmc/ https://www.sages.org/meetings/annual-meeting/abstracts-archive/cost-analysis-of-robotic-assisted-surgery-vs-laparoscopy-in-general-surgery/ https://my.clevelandclinic.org/health/treatments/22178-robotic-surgery https://www.narayanahealth.org/blog/future-of-robotic-surgery/ https://www.market-prospects.com/articles/what-is-a-surgical-robot https://www.mayoclinic.org/tests-procedures/robotic-surgery/about/pac-20394974 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Surgical Robots Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Surgical Robots Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021-2030 (USD Million) 4.4 End-User Business Analysis 4.4.1 Market, By End-User, 2021-2030 (USD Million) 4.5 Application Business Analysis 4.5.1 Market, By Application, 2021-2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturing Sites, Area Served, End-User 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Application Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Orthopaedics 7.3.1. Orthopaedics, Market, 2021-2030 (USD Million) 7.4. Neurology 7.4.1. Neurology, Market, 2021-2030 (USD Million) 7.5. Urology 7.5.1. Urology, Market, 2021-2030 (USD Million) 7.6. Gynaecology 7.6.1. Gynaecology, Market, 2021-2030 (USD Million) 7.7. General Surgery 7.7.1. General Surgery, Market, 2021-2030 (USD Million) 7.8. Others 7.8.1. Others, Market, 2021-2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021-2030 (USD Million) 8.4. Ambulatory Surgical Centres 8.4.1. Ambulatory Surgical Centres market, 2021-2030 (USD Million) 8.5 Others 8.5.1 Others market, 2021-2030 (USD Million) 9. Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By End-User, 2021-2030 (USD Million) 9.1.4. North America Market, By Application, 2021-2030 (USD Million) 9.1.5. North America Market, by Country, 2021-2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By End-User, 2021-2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By End-User, 2021-2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021-2030 (USD Million) 9.1.4.2.3. Canada Market, by Applications, 2021-2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By End-User, 2021-2030 (USD Million) 9.2.2. Europe Market, by By Application, 2021-2030 (USD Million) 9.2.5. Europe Market, by country, 2021-2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By End-User, 2021-2030 (USD Million) 9.2.4.1.2. U.K. Market, By Applications, 2021-2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021-2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By End-User, 2021-2030 (USD Million) 9.2.4.2.2. Germany Market, By Application, 2021-2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021-2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By End-User, 2021-2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021-2030 (USD Million) 9.2.4.3.3. France Market, by Application, 2021-2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By End-User, 2021-2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021-2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by Application, 2021-2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By End-User, 2021-2030 (USD Million) 9.3.2. Asia Pacific Market, By Application, 2021-2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021-2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By End-User, 2021-2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021-2030 (USD Million) 9.3.4.1.3. China Market, by Application, 2021-2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By End-User, 2021-2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021-2030 (USD Million) 9.3.4.2.3. India Market, by Application, 2021-2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By End-User, 2021-2030 (USD Million) 9.3.4.3.3. Japan Market, by Application, 2021-2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By End-User, 2021-2030 (USD Million) 9.3.4.4.3. South Korea Market, by Application, 2021-2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021-2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By End-User, 2021-2030 (USD Million) 9.4.3. Latin America Market, by Application, 2021-2030 (USD Million) 9.4.4. Latin America Market, by country, 2021-2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By End-User, 2021-2030 (USD Million) 9.4.4.1.3. Brazil Market, by Application, 2021-2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By End-User, 2021-2030 (USD Million) 9.4.4.2.3. Mexico Market, by Application, 2021-2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By End-User, 2021-2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by Application, 2021-2030 (USD Million) 9.5. MEA 9.5.1. MEA Market, By End-User, 2021-2030 (USD Million) 9.5.3. MEA Market, by Application, 2021-2030 (USD Million) 10. Competitive Landscape 10.1 Intuitive Surgical. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. ProductPortfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Stryker Corporation 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. Medtronic. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Smith & Nephew. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Zimmer Biomet 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Asensus Surgical (Transenterix). 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. Corindus Vascular Robotics. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Renishaw. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Auris Health. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Medrobotics Corporation. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. Think Surgical. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. Verb Surgical. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. OMNIlife Science. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. CMR Surgical. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. Preceyes BV. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development 10.16. China National Scientific Instruments and Materials Corporation 10.16.1. Company overview 10.16.2. Financial performance 10.16.3. Product Portfolio Analysis 10.16.4. Business Strategy & Recent Development 10.17. Microsure. 10.17.1. Company overview 10.17.2. Financial performance 10.17.3. Product Portfolio Analysis 10.17.4. Business Strategy & Recent Development 10.18. Titan Medical. 10.18.1. Company overview 10.18.2. Financial performance 10.18.3. Product Portfolio Analysis 10.18.4. Business Strategy & Recent Development 10.19. Avateramedical GmbH. 10.19.1. Company overview 10.19.2. Financial performance 10.19.3. Product Portfolio Analysis 10.19.4. Business Strategy & Recent Development 10.20. Medicaroid Corporation. 10.20.1. Company overview 10.20.2. Financial performance 10.20.3. Product Portfolio Analysis 10.20.4. Business Strategy & Recent Development List of Tables (67 Tables) TABLE 1. MARKET, By Application, 2021-2030 (USD Million) TABLE 2. MARKET FOR Orthopaedics, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Neurology, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Urology, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Gynaecology, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR General Surgery, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, BY End-User, 2021-2030 (USD Million) TABLE 9. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Ambulatory Surgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 12. Market, BY REGION, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, BY Applications, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 16. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 17. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 18. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 19. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 23. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 25. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 26. Intuitive Surgical: COMPANY SNAPSHOT TABLE 27. Intuitive Surgical: OPERATING SEGMENTS TABLE 28. Stryker Corporation: COMPANY SNAPSHOT TABLE 29. Stryker Corporation: OPERATING SEGMENTS TABLE 30. Medtronic: COMPANY SNAPSHOT TABLE 31. Medtronic: OPERATING SEGMENTS TABLE 32. Smith & Nephew: COMPANY SNAPSHOT TABLE 33. Smith & Nephew: OPERATING SEGMENTS TABLE 34. Zimmer Biomet: COMPANY SNAPSHOT TABLE 35. Zimmer Biomet: OPERATING SEGMENTS TABLE 36. Asensus Surgical (Transenterix): COMPANY SNAPSHOT TABLE 37. Asensus Surgical (Transenterix): OPERATING SEGMENTS TABLE 38. Corindus Vascular Robotics: COMPANY SNAPSHOT TABLE 39. Corindus Vascular Robotics: OPERATING SEGMENTS TABLE 40. Renishaw: COMPANY SNAPSHOT TABLE 41. Renishaw: OPERATING SEGMENTS TABLE 42. Auris Health: COMPANY SNAPSHOT TABLE 43. Auris Health: OPERATING SEGMENTS TABLE 44. Medrobotics Corporation: COMPANY SNAPSHOT TABLE 45. Medrobotics Corporation: OPERATING SEGMENTS TABLE 46. Think Surgical: COMPANY SNAPSHOT TABLE 47. Think Surgical: OPERATING SEGMENTS TABLE 48. Verb Surgical.: COMPANY SNAPSHOT TABLE 49. Verb Surgical.: OPERATING SEGMENTS TABLE 50. OMNIlife Science: COMPANY SNAPSHOT TABLE 51. OMNIlife Science: OPERATING SEGMENTS TABLE 52. CMR Surgical: COMPANY SNAPSHOT TABLE 53. CMR Surgical: OPERATING SEGMENTS TABLE 54. Preceyes BV: COMPANY SNAPSHOT TABLE 55. Preceyes BV: OPERATING SEGMENTS TABLE 56. China National Scientific Instruments and Materials Corporation: COMPANY SNAPSHOT TABLE 57. China National Scientific Instruments and Materials Corporation: OPERATING SEGMENTS TABLE 58. Microsure: COMPANY SNAPSHOT TABLE 59. Microsure: OPERATING SEGMENTS TABLE 60. Titan Medical: COMPANY SNAPSHOT TABLE 61. Titan Medical: OPERATING SEGMENTS TABLE 62. Avateramedical GmbH: COMPANY SNAPSHOT TABLE 63. Avateramedical GmbH: OPERATING SEGMENTS TABLE 64. Medicaroid Corporation: COMPANY SNAPSHOT TABLE 65. Medicaroid Corporation: OPERATING SEGMENTS TABLE 66. Sebbin: COMPANY SNAPSHOT TABLE 67. Sebbin: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 20 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Surgical Robots, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Surgical Robots, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Applications, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By End-User, 2019 vs. 2025 Figure 13 Geographical Snapshot of the Market Figure 14 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 15 General Surgery to Witness Higher CAGR in the Market for Application Segment during the Forecast Period. Figure 16 Asia-Pacific Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: Market Snapshot Figure 19 Asia Pacific: Market Snapshot Figure 20 Vendor Dive: Evaluation Overview